Edmund and Irmgard Römer Foundation helps researchers

Human cytomegalovirus infections often have a poor prognosis for disease in immunocompromised cancer patients. While the virus is known to cause pneumonia and diarrhoeal disease, work from the Interdisciplinary Paediatric Tumour and Virus Research Laboratory shows that it also has a direct impact on the effectiveness of cancer therapeutics. For example, the virus causes chemotherapy resistance in neuroblastomas, one of the most common solid tumours in children and adolescents, and leads to increased tumour growth. The research project now supported by the Edmund and Irmgard Römer Foundation with 10.000,- EURO under the direction of Dr. Jens-Uwe Vogel helps to better understand the pathogenesis of cytomegalovirus infections and to advance the development of new therapies. We thank the Edmund and Irmgard Römer Foundation for this important help. This support brings us one step closer to our vision of being able to cure all children suffering from cancer in the future.